GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (MEX:BMY) » Definitions » Beginning Cash Position

Bristol-Myers Squibb Co (MEX:BMY) Beginning Cash Position : MXN211,681 Mil (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Bristol-Myers Squibb Co Beginning Cash Position?

Bristol-Myers Squibb Co's Beginning Cash Position for the quarter that ended in Mar. 2025 was MXN211,681 Mil.

Bristol-Myers Squibb Co's quarterly Beginning Cash Position increased from Sep. 2024 (MXN123,970 Mil) to Dec. 2024 (MXN164,614 Mil) and increased from Dec. 2024 (MXN164,614 Mil) to Mar. 2025 (MXN211,681 Mil).

Bristol-Myers Squibb Co's annual Beginning Cash Position declined from Dec. 2022 (MXN279,105 Mil) to Dec. 2023 (MXN158,285 Mil) but then increased from Dec. 2023 (MXN158,285 Mil) to Dec. 2024 (MXN240,237 Mil).

Bristol-Myers Squibb Co Beginning Cash Position Historical Data

The historical data trend for Bristol-Myers Squibb Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Beginning Cash Position Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 255,015.44 307,156.12 279,104.74 158,284.86 240,236.81

Bristol-Myers Squibb Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 191,172.26 170,999.84 123,970.13 164,614.04 211,681.00

Bristol-Myers Squibb Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Bristol-Myers Squibb Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (MEX:BMY) » Definitions » Beginning Cash Position
Comparable Companies
GILD PFE AMGN BIIB OGN AMRN MDCX SCLX MIRA MRK LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN TSE:4519 LSE:GSK
Traded in Other Exchanges
BMYMP.PFD:USA BMY:USA BMY:Peru 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina
Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Website
https://www.bms.com
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.